Xbrane Drops Keytruda Rival As It Pares Down Pipeline And Personnel

Swedish Biosimilars Developer Discloses ‘Unfortunately Necessary Measures’ To Cut Costs

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.